Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars


October 30, 2015
MEDdesign

Science Fiction Meets Nano-Robots

By Klaus Jopp

A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.

Continue reading →

October 29, 2015

Digital Health Hot Topic at RAPS 2015

By Maria Fontanazza

Managing data, interoperability and cybersecurity issues were at the top of the list for industry stakeholders.

Continue reading →

Finger prick lab tests, Theranos
October 28, 2015
Finger prick lab tests, Theranos

FDA Says Theranos Device Uncleared, Finds Host of Problems

By Maria Fontanazza

Mainstream media attention catapulted the company to the center of controversy for its finger-prick lab tests. Now FDA has taken issue with the company’s complaint handling and design validation.

Continue reading →

October 26, 2015

2015 Update on the Diabetes Market In Asia

By Ames Gross

As the incidence of diabetes across Asia expands, demand for medical devices and drugs to treat the disease is intensifying.

Continue reading →

Maria Fontanazza and Ian Strickland discuss future of medtech market at AdvaMed 2015
October 15, 2015
Maria Fontanazza and Ian Strickland discuss future of medtech market at AdvaMed 2015

MedTech Market to Hit $470 Billion by 2020, Prepare for Consolidation

By MedTech Intelligence Staff

Expect to see slow growth and more mergers & acquisitions.

Continue reading →

John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015
October 14, 2015
John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015

2015 MedTech Highlights: Low Industry Growth, VC Declines, M&A Impressive

By MedTech Intelligence Staff

Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.

Continue reading →

Nicole Littman, Quorum Consulting
October 8, 2015
Nicole Littman, Quorum Consulting
Soapbox

CMS Reveals Rationale for NTAP Decisions in Rule Making

By Nicole Littmann

What can we learn about how new technologies become eligible for additional payment?

Continue reading →

Pediatric technologies
October 8, 2015
Pediatric technologies

MedTech Designers: Children Are Not Small Adults

By Maria Fontanazza

There is a great unmet need for pediatric-specific devices. Why aren’t more manufacturers addressing this critical area?

Continue reading →

October 7, 2015
Ameing for Asia

Key Regulatory Issues for Establishing New Green Field Device Factory in China

By Ames Gross

Remember, several basic regulatory approvals are required.

Continue reading →

MobileODT, Clinician uses device
October 1, 2015
MobileODT, Clinician uses device

Mobile Technology Ready to Change Standard of Care in Cervical Cancer Detection

By Maria Fontanazza

The technology platform has already gone global and has the potential to be a true breakthrough in screening and detecting several types of cancer.

Continue reading →

Post navigation

  • Previous
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 97
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

May 20, 2026

Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity

By Peter Justen

MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Peter Justen is Founder and CEO of AmeriTrust Solutions. He works at the intersection of technology, data, and human-centered design to improve access to government...

May 20, 2026

The failure of the ‘usual suspects’ approach to life science recruitment

By Ivor Campbell

How has AI impacted the way in which companies recruit for senior specialists, particularly in highly niche roles in MedTech, biotech and pharmaceutical development? Finding the right people for these roles has never been harder.

May 20, 2026

Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.

By Joan Hinrichs
Justice scale, healthcare, cost

Market Access is now the central input into M&A and value-driven divestitures, enabling MedTech leaders to reshape portfolios for strategic advantage, long-term growth, and greater value to patients - unlocking their full potential.

May 20, 2026

The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation

By Evan Butler

Boston Children’s Hospital physicians say one of the greatest risks in pediatric ICUs is delayed de-escalation of care, which can expose children to prolonged ventilation, sedation, and vasoactive medications. They argue that AI-driven clinical intelligence can help clinicians identify safer timing for weaning and extubation, supporting recovery and improving long-term outcomes.

May 20, 2026

Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System

By MedTech Intelligence Staff

Artivion has finalized its acquisition of Endospan Ltd., adding the FDA-approved NEXUS Aortic Arch System to its portfolio of aortic arch therapies. The deal strengthens the company’s position in the growing endovascular aortic repair market and adds a pipeline of next-generation arch technologies.

May 19, 2026

Global MedTech Contract Manufactures Finalize Merger

By MedTech Intelligence Staff

Tecomet and Orchid Orthopedic Solutions have completed a merger to create a larger global contract manufacturing platform serving MedTech and Aerospace & Defense customers with expanded capabilities and supply chain reach.

May 19, 2026

Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort

By MedTech Intelligence Staff

Up to 1,000 jobs globally could be cut over the next three years as part of a major restructuring effort following weaker first-half earnings driven by declining sales, currency pressures, and weak market demand.

May 19, 2026

Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer

By MedTech Intelligence Staff

Marks the first FDA-approved use of personalized molecular residual disease (MRD) testing to guide treatment decisions and solidifies Natera’s Treatment on MRD (TOMR) approach for MIBC care.

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.